Compared to the LV-NC group, the LV-Si-UBQLN4 group had a much smaller mean tumor volume and tumor weight (Fig. 7A–C), manifesting that targeted knockdown of UBQLN4 expression effectively inhibited tumor proliferation in vivo. Here, UBQLN4 is linked to neoplasm.